PARTICIPATING SITES
We are proud to collaborate with Australia’s leading hospitals and medical research institutes. Together, we are advancing the future of lung cancer care for all Australians affected, regardless of background, location, or circumstances.
SUPPORTING PARTNERS
We are thankful to all our partners who have contributed their expertise, support, technology, and advocacy to make TRACKER a reality. Your invaluable contributions have brought this project to life, and we are deeply appreciative of the commitment shown by each of you.
TSANZ supports TRACKER through lung disease research, education, and dissemination to respiratory professionals.
The Olivia Newton-John Cancer Research Institute supports research into more effective, tolerable, and accessible cancer care, and hosts TRACKER's core coordination team.
LFA promotes lung health through advocacy for research, policy reform, and equitable access to care, and supports TRACKER through funding and increased awareness.
TOGA promotes best practice lung cancer care through research, clinical trials, and advocacy, and supports TRACKER through funding and increased awareness.
Illumina supports TRACKER as a leader in next-generation sequencing technology, providing in-kind support for sequencing and access to cloud-based data storage.
10X supports TRACKER as a leader in gene sequencing technology for research, providing subsidised reagents and technical support.
MSD develops medicines and vaccines to address major global health threats and supports collaborative opportunities in preclinical and clinical studies arising from TRACKER.
MRV supports TRACKER as an example of world-class biobanking practices that facilitate high-quality research.
Cancer Trials Australia supports TRACKER by helping maximise the translational impact of our activities.
WEHI facilitates our single-cell analysis of lung cancer tissue, hosting all TRACKER omics data, and supporting integrative bioinformatics analyses.
PMCC supports TRACKER through specialised expertise and infrastructure for the analysis of liquid biopsy samples.
FUNDING BODIES
We express our sincere gratitude to all the funding whose generous contributions have made the TRACKER a reality. Our team deeply appreciates the invaluable support extended by the following funding bodies, which has been instrumental in bringing this project to fruition.
National Health and Medical Research Council (NHMRC) Fellowship
Priority-driven Collaborative Cancer Research Scheme
-
Helen Irving Memorial Award
-
Cassy Morris Innovation Grant
-
Deep Manchanda Strategic Partnerships Grant
Medical Research Future Fund (MRFF)
Inspirational Research Grants
Austin Medical Research Foundation Grant
